Stockreport

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF NEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D Path , a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tum [Read more]